Blog - Page 4044 of 5386

MondayNov 03, 2008 7:02 am

Changing Times Vitamins, Inc. (SGTB.PK) Announces QualityStocks Coverage

Changing Times Vitamins, Inc. will be featured in upcoming Daily Newsletters, Daily Blogs, Message Boards, and the Small Cap Daily Internet broadcasts put out by QualityStocks. QualityStocks has over 740,000 subscribers to The Daily Stock Newsletter, which is a free service that collects data from hundreds of Small-Cap and Micro-Cap online Investment Newsletters and puts it all into one Free Daily Newsletter Report. Changing Times Vitamins, Inc. is focused on developing a network of synergistic divisions that will offer proprietary Natural Health & Fitness Products, technology for Athletic Community Web Sites, Sports Event Promotions and Total Body Fitness-oriented Health Clubs.…

MondayNov 03, 2008 7:02 am

ICU Medical, Inc. (NASDAQ: ICUI)

ICU Medical, Inc. (NASDAQ: ICUI), founded in 1984 by Dr. George Lopez, a practicing internist who believed there was a better way of securing I.V. lines, is focused on developing and manufacturing products that both protect the Health Care worker from accidental needle sticks as well as protect the reliability of IV systems. With an approximate market cap of nearly 500 million, ICU’s products include the CLAVE NeedleFree Connector and the CLC2000 Catheter Patency Device. For further information, visit the Company's web site at www.icumed.com.

MondayNov 03, 2008 7:01 am

Icagen, Inc. (NASDAQ: ICGN)

Icagen, Inc. (NASDAQ: ICGN) is a biopharmaceutical company based in Research Triangle Park, North Carolina, focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. Utilizing its proprietary know-how and integrated scientific and drug development capabilities, Icagen has identified multiple drug candidates that modulate ion channels. The Company is conducting research and development activities, in some cases in collaboration with leading pharmaceutical companies, in a number of disease areas, including epilepsy, pain and inflammation. The Company has clinical stage programs in epilepsy and asthma. For further information, visit the Company's web site…

MondayNov 03, 2008 7:01 am

ICP Solar Technologies, Inc. (OTC BB: ICPR)

ICP Solar Technologies, Inc. (OTC BB: ICPR), a developer, manufacturer and marketer of solar panels and solar cell based products as well as building materials, seeks to build name recognition in three high growth solar categories: recreational, industrial, and residential. By leveraging next-generation technologies and using proprietary intellectual design, the Company aims to be the industry's innovation leader. The company's headquarters are located in Montreal, Canada. For further information, visit the Company's web site at www.icpsolar.com.

MondayNov 03, 2008 7:00 am

iCAD, Inc. (NASDAQ: ICAD)

iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions, enables healthcare professionals to identify pathologies and pinpointing cancer earlier. The company provides a broad range of high-performance, upgradeable CAD systems and workflow solutions for mammography, Magnetic Resonance Imaging (MRI), and Computed Tomography (CT). iCAD's solutions are available in more than 2,200 healthcare centers worldwide. For further information, visit the Company's web site at www.icadmed.com.

MondayNov 03, 2008 6:59 am

Hythiam, Inc. (NASDAQ: HYTM)

Hythiam, Inc. (NASDAQ: HYTM) is focused on providing comprehensive behavioral health management services to health plans, employers, criminal justice, and government agencies. Additionally, the company researches, develops, licenses and commercializes innovative and proprietary physiological, nutritional, and behavioral treatment programs. Currently, Hythiam provides initial disease management offerings that incorporate medical and behavioral treatments for substance dependence. For further information, visit the Company's web site at www.hythiam.com.

MondayNov 03, 2008 6:59 am

Hudson Technologies, Inc. (NASDAQ: HDSN)

Hudson Technologies, Inc. (NASDAQ: HDSN), a leading provider of traditional reclamation services and refrigerant sales to the commercial and industrial air conditioning and refrigeration markets, provides innovative solutions to recurring problems within the refrigeration industry. The company’s RefrigerantSide® Services increase operating efficiency and energy savings, and remove moisture, oils and other contaminants. For further information, visit the Company's web site at www.hudsontech.com.

MondayNov 03, 2008 6:58 am

Hong Kong Highpower Technology, Inc. (AMEX: HPJ)

Hong Kong Highpower Technology, Inc. (AMEX: HPJ) is a holding company that specializes in the development and manufacturing of nickel metal hydride (Ni-MH) rechargeable battery cells through its manufacturing facilities in China. The company’s rechargeable batteries allow it to capitalize in electronic and industrial applications. Hong Kong Highpower Technology is led by Dang Yu Pan who serves as both CEO and Chairman of the company. For further information, visit the company website at: www.haopengbattery.com.

MondayNov 03, 2008 6:57 am

Homeland Energy Group Ltd. (TSX: HEG CN)

Homeland Energy Group Ltd. (TSX: HEG CN) has its efforts focused on producing coal from existing South African mines, resource development in South Africa, energy exploration in southern Africa and strategic acquisitions of properties and projects that support continued growth of Homelands energy resources and reserves. The company’s Eloff Mining Project, currently in the development stage, has an estimated 452 million tonnes (Measured and Indicated) of coal. For further information, visit the Company's web site at www.homelandcorp.com.

MondayNov 03, 2008 6:57 am

Hollis-Eden Pharmaceuticals, Inc. (NASDAQ: HEPH)

Hollis-Eden Pharmaceuticals, Inc. (NASDAQ: HEPH) is focused on developing a proprietary class of adrenal steroid hormones as innovative pharmaceuticals for human health. Through its Hormonal Signaling Technology Platform, the company is developing a new series of small molecule compounds that are metabolites or synthetic analogs of endogenous hormones derived by the adrenal glands from the body’s most abundant circulating adrenal steroid. For further information, visit the Company's web site at www.holliseden.com.

Site Search

Company Search